International Stem Cell (OTCMKTS:ISCO) Stock Passes Above Two Hundred Day Moving Average – Time to Sell?

International Stem Cell Corp. (OTCMKTS:ISCO) shares crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.15 and traded as high as $0.1589. International Stem Cell shares last traded at $0.1351, with a volume of 1,250 shares.

International Stem Cell Stock Performance

The company has a 50 day moving average of $0.16 and a 200-day moving average of $0.15. The stock has a market cap of $1.08 million, a price-to-earnings ratio of -2.25 and a beta of 0.05.

International Stem Cell (OTCMKTS:ISCO) last issued its quarterly earnings results on Monday, March 30th. The biotechnology company reported ($0.04) earnings per share for the quarter. The business had revenue of $2.15 million during the quarter.

International Stem Cell Company Profile

International Stem Cell Corporation (OTCMKTS:ISCO) is a biotechnology company focused on the development and commercialization of human parthenogenetic stem cells (hpSC) for therapeutic and research applications. Parthenogenetic stem cells are derived from unfertilized human eggs and offer a scalable, ethically noncontroversial source of pluripotent cells. ISCO’s proprietary hpSC lines can be directed to differentiate into a wide variety of cell types, enabling preclinical programs in areas such as neurodegenerative disease, liver disease, diabetes and corneal regeneration.

In addition to its therapeutic pipeline, International Stem Cell maintains a research products division that supplies hpSC lines, differentiated cell populations and media formulations to academic institutions, biotechnology companies and contract research organizations.